Concentrations	9 Months Ended
Sep. 30, 2015
Risks And Uncertainties [Abstract]
Concentrations	(9) CONCENTRATIONS The Company sourced approximately 32% and 21% of components for its electrotherapy products from one vendor during the nine months ended September 30, 2015 and 2014, respectively. Management believes that its relationships with suppliers are good; however, the Company has delayed and extended payments to many of its vendors for cash flow reasons, which has caused many of its vendors to require pre-payment for products or services. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. The Company had receivables from a private health insurance carrier at September 30, 2015 and December 31, 2014, that made up approximately 7% and 10%, respectively, of the net accounts receivable balance.

Concentrations

9 Months Ended

Sep. 30, 2015

(9) CONCENTRATIONS

The Company sourced approximately 32% and 21% of components for its electrotherapy products from one vendor during the nine months ended September 30, 2015 and 2014, respectively. Management believes that its relationships with suppliers are good; however, the Company has delayed and extended payments to many of its vendors for cash flow reasons, which has caused many of its vendors to require pre-payment for products or services. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.

The Company had receivables from a private health insurance carrier at September 30, 2015 and December 31, 2014, that made up approximately 7% and 10%, respectively, of the net accounts receivable balance.